GlassScriptPhysician profile
Amir Kashefi
NPI 1558591933
$7,067.36
in general payments reported to CMS, 2019-2025
20 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,325 · 2020: $116 · 2021: $299 · 2022: $4,112 · 2023: $343 · 2024: $320 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063 · Travel and Lodging: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.27 |
| Travel and Lodging | $151.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $4,145.34 | 2022-2025 | Trinav Infusion System |
| Angiodynamics, INC. | $1,414.39 | 2019-2025 | Auryon Laser System 100-120 Vac, Micro Access |
| Acadia Pharmaceuticals INC | $246.12 | 2023 | Nuplazid |
| Globus Medical, INC. | $191.01 | 2025 | Senza |
| Bard Peripheral Vascular, INC. | $169.56 | 2021-2025 | Pristine |
| Stryker Corporation | $169.19 | 2020-2024 | Optablate |
| Spr Therapeutics, INC | $151.57 | 2025 | Sprint Pns System |
| Nevro Corp. | $117.70 | 2024 | Senza |
| Boston Scientific Corporation | $85.38 | 2020-2021 | |
| Merit Medical Systems INC | $81.43 | 2025 | |
| Biogen, INC. | $59.88 | 2021-2023 | Spinraza |
| Cordis US Corp. | $37.86 | 2025 | Mynx Control |
| Inari Medical, INC. | $35.63 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $34.96 | 2021-2022 | |
| Medtronic Vascular, INC. | $32.40 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ekos Corporation | $32.28 | 2019 | |
| Philips North America LLC | $20.77 | 2021 | |
| Alnylam Pharmaceuticals INC. | $17.75 | 2023 | Onpattro |
| Glaxosmithkline, LLC. | $17.64 | 2020 | |
| Venclose INC. | $6.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Kashefi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.